Cite
MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis.
MLA
Das, Swadesh K., et al. “MDA-9/Syntenin (SDCBP): Novel Gene and Therapeutic Target for Cancer Metastasis.” Pharmacological Research, vol. 155, May 2020, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.phrs.2020.104695.
APA
Das, S. K., Maji, S., Wechman, S. L., Bhoopathi, P., Pradhan, A. K., Talukdar, S., Sarkar, D., Landry, J., Guo, C., Wang, X.-Y., Cavenee, W. K., Emdad, L., & Fisher, P. B. (2020). MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis. Pharmacological Research, 155, N.PAG. https://doi.org/10.1016/j.phrs.2020.104695
Chicago
Das, Swadesh K., Santanu Maji, Stephen L. Wechman, Praveen Bhoopathi, Anjan K. Pradhan, Sarmistha Talukdar, Devanand Sarkar, et al. 2020. “MDA-9/Syntenin (SDCBP): Novel Gene and Therapeutic Target for Cancer Metastasis.” Pharmacological Research 155 (May): N.PAG. doi:10.1016/j.phrs.2020.104695.